The Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer Treated With Novel Hormonal Therapy or Chemotherapy: A Systematic Review and Meta-analysis

The Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer Treated With Novel Hormonal Therapy or Chemotherapy: A Systematic Review and Meta-analysis

PurposeThis study aimed to evaluate the prognostic role of AR-V7 in terms of prostate-specific antigen (PSA) response, progression-free survival (PFS), and overall survival (OS) in CRPC patients treated with novel hormonal therapy (NHT) (Abiraterone and Enzalutamide) or taxane-based chemotherapy (Do...

Full description

Bibliographic Details
Main Authors: Zhize Wang, Haixiang Shen, Nieying Ma, Qinchen Li, Yeqing Mao, Chaojun Wang, Liping Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Oncology
Subjects:
androgen receptor splicing variant 7
novel hormonal therapy
chemotherapy
prostate cancer
predictor
survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.572590/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.572590/full

Similar Items